- Home
- SRRK vs MAC Comparison
SRRK vs MAC Comparison
Compare SRRK & MAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRRK | MAC |
|---|---|---|
| Founded | 2012 | 1964 |
| Country | United States | United States |
| Employees | N/A | 2845 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.8B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SRRK | MAC |
|---|---|---|
| Price | $44.60 | $20.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $51.20 | $20.03 |
| AVG Volume (30 Days) | 757.3K | ★ 2.2M |
| Earning Date | 04-10-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | ★ 11.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,013,983,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21,831.23 | $0.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.43 |
| 52 Week Low | $22.71 | $12.48 |
| 52 Week High | $49.82 | $20.85 |
Technical Indicators
Market Signals| Indicator | SRRK | MAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 67.00 |
| Support Level | $42.74 | $17.77 |
| Resistance Level | $48.79 | N/A |
| Average True Range (ATR) | 1.76 | 0.65 |
| MACD | -0.25 | 0.18 |
| Stochastic Oscillator | 8.71 | 96.34 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About MAC Macerich Company (The)
Macerich invests in premium mall assets. The company owns 29 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with two power centers and seven other real estate assets. The company's total portfolio has 42.2 million square feet of gross leasable area and averaged $849 sales per square foot over the 12 months ended in June 2025.